Knowledge Center
Patent / Aug 04, 2022
Inhaled ivermectin
Source:
US 20220241307
The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Also in the Knowledge Center
Scientific Article
/ Nov 19, 2018
Webinar - Amorphous Solid Dispersions: Increasing Solubility From API to Tablet
Read more
Scientific Article
/ Nov 30, 2016
Webinar - DPI carrier-based formulation: integrating enhanced aerodynamic performance with manufacturability
Read more
Scientific Article